MedTrace Logo

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine

NCT02153866 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2014-06-03

No results posted yet for this study

Summary

Nowadays these are some vaccines being vaccinated simultaneously, and a doubt is aroused if the safety and immunogenicity are same between inoculating several vaccines simultaneously and inoculating individually. So we carry out this study.

The purpose of this study is to evaluate the difference of safety and immunogenicity on vaccinating rotavirus vaccine simultaneously with measles-rubella vaccine(MR) or measles-mumps-rubella vaccine(MMR) compared to vaccinating rotavirus vaccine, MR or MMR individually.

Conditions

  • Rotavirus

Interventions

BIOLOGICAL

rotavirus vaccine

3ml/dose, oral

BIOLOGICAL

measles-rubella vaccine

0.5ml per dose, subcutaneous injection

BIOLOGICAL

measles-mumps-rubella vaccine

0.5ml per dose, subcutaneous injection

Sponsors & Collaborators

  • China National Biotec Group Company Limited

    collaborator INDUSTRY

  • Sichuan Center for Disease Control and Prevention

    lead OTHER_GOV

Principal Investigators

  • rui ao, Master · Sichuan provincial center for disease control and prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
8 Months
Max Age
9 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-05-31
Completion
2014-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02153866 on ClinicalTrials.gov